Executive officer

Nicholas Corcoran

Senior Vice President of Supply Chain and Operations·TransMedics Group, Inc.

About

Nicholas Corcoran has served as TransMedics' Senior Vice President of Supply Chain and Operations since January 2023.

Prior to joining TransMedics he served at Stryker Corporation as Vice President of Division Operations (Joint Replacement) from April 2022, managing the division's entire supply chain, and previously as Vice President of Division and Commercial Operations (Spine) from 2020 until 2022, Senior Director of Division Operations from 2018 until 2020, and Director of Global Sourcing.

He earlier held supply chain and operations roles at Waters Corporation and Intel Corporation, and holds a Bachelor's Degree in Finance and Economics from South East Technological University and a Master's of Business in Supply Chain Management from University College Dublin's Smurfit School of Business.

Since January 2023
Age 44
Tenure 3 yrs

Also at TransMedics Group, Inc.

WM Waleed H. Hassanein, M.D. Founder, President and Chief Executive Officer; Director JT James R. Tobin Director; Chairperson of the Board EB Edward M. Basile Director; Chairperson of the Nominating and Corporate Governance Committee TG Thomas J. Gunderson Director; Chairperson of the Compensation Committee EJ Edwin M. Kania, Jr. Director SL Stephanie Lovell Director

Roles

Organization Role Dates Details
TransMedics Group, Inc. Senior Vice President of Supply Chain and Operations January 2023–present Current role
Stryker Corporation Vice President of Division Operations (Joint Replacement) Since April 2022; managed the division's entire supply chain including internal manufacturing sites and external supply partners.
Stryker Corporation Vice President of Division and Commercial Operations (Spine) 2020-2022
Stryker Corporation Senior Director of Division Operations 2018-2020 Previously Director of Global Sourcing.
Waters Corporation Supply chain and operations roles
Intel Corporation Supply chain and operations roles

Related

Source: TransMedics Group, Inc. proxy statement (SEC Schedule 14A)

Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.

See how VectorShift works for your firm

Request Demo